Reimbursement Information

Novartis Pharmaceuticals Corporation is pleased to provide you with a Coding and Billing Reference Sheet to serve as a resource when submitting claims for myfortic® (mycophenolic acid) delayed-release tablet. Proper coding helps facilitate processing and reduces the risk of denied claims. Coding requirements vary by the setting from which myfortic, an enteric-coated formulation of mycophenolic acid, is administered and dispensed. Also included in this section is information about the Reimbursement Hotline.